WHO joined delegations from 130 countries at the 149th Assembly of the Inter-Parliamentary Union (IPU) in Geneva. The Assembly addressed global health challenges like conflicts, disasters, and climate crises.
Its theme focused on using science, technology, and innovation for a better future.
Dr. Gaudenz Silberschmidt, WHO’s Director for Health and Multilateral Partnerships, highlighted the need for urgent action. He said science must address today’s challenges while promoting equity.
He called parliamentarians to finalize a pandemic preparedness accord and secure health financing.
“This will not happen by itself,” Dr. Gaudenz Silberschmidt said.
Decisions made by leaders, he added, could shape global health outcomes. WHO urged lawmakers to act decisively and prioritize health.
WHO and IPU have long worked to bridge the gap between science and policy. At the IPU Advisory Group on Health, WHO emphasized the importance of monitoring progress on universal health coverage (UHC).
Accountability plays a key role in advancing health goals. WHO provides parliamentarians with reliable data to guide their actions.
Sexual and reproductive health and rights (SRHR) took center stage during the Assembly. Delegates from countries like Malawi, Suriname, and Zambia participated in a workshop, sharing experiences on challenges such as adolescent pregnancy and early child marriage.
Hon. Cheryl Dijksteel from Suriname described her country’s approach. She stressed the need for comprehensive sexuality education programs both in schools and communities. Removing legal barriers, she said, ensures adolescents can access critical reproductive health services.
Maternal health was another primary focus. It remains a high priority following commitments made at the Seventy-seventh World Health Assembly.
However, substandard medicines continue to threaten the lives of pregnant women and newborns.
An event held alongside the IPU Assembly highlighted this issue. It brought together parliamentarians from affected nations and health experts. They explored solutions to ensure the availability of quality-assured maternal health medicines.
The discussions underscored the importance of science and innovation in driving change. Policymakers play a critical role in turning research into action.
By doing so, they can address health inequities and benefit the most vulnerable populations.
Dr. Silberschmidt urged leaders to take bold steps. He reminded them that their decisions can shape a healthier future. WHO’s collaboration with IPU remains pivotal in making science work for everyone.